GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

This has lagged the Medical sector's gain of 1.64% and the S&P 500's gain of 2.08% in that time. Investors will be eagerly watching for the performance of Eli Lilly in its upcoming earnings ...

US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...

Medical industry giants Eli Lilly and Merck will collaborate with Purdue through a new institute, which aims to advance ...

Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches boosting long-term growth.

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

surpassing the Medical sector's loss of 6.22% and falling behind the S&P 500's loss of 1.7%. Investors will be eagerly watching for the performance of Eli Lilly in its upcoming earnings disclosure.

and delivering life-changing medicines to address some of the world's most pressing medical needs. With a market cap of $759.4 billion, Eli Lilly operates across diverse therapeutic areas ...

Eli Lilly is seeking to end a lawsuit filed by ... And in the nearly two years that tirzepatide was in shortage, telehealth companies, medical spas and other clients of compounding pharmacies ...